Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Cao, T. George, V. Prima, D. Nelson, S. Svetlov (2013)
Argininosuccinate synthase as a novel biomarker for inflammatory conditionsBiomarkers, 18
Jin Wang, Yong-hong Yang, An-qun Wang, B. Yao, G. Xie, G. Feng, Yu Zhang, Zong-Shu Cheng, L. Hui, T. Dai, X. Du, Dong Wang (2010)
Immunohistochemical detection of the Raf kinase inhibitor protein in nonneoplastic gastric tissue and gastric cancer tissueMedical Oncology, 27
M. D'errico, E. Rinaldis, M. Blasi, V. Viti, M. Falchetti, A. Calcagnile, F. Sera, C. Saieva, L. Ottini, D. Palli, F. Palombo, A. Giuliani, E. Dogliotti (2009)
Genome-wide expression profile of sporadic gastric cancers with microsatellite instability.European journal of cancer, 45 3
B. Delage, D. Fennell, L. Nicholson, I. McNeish, N. Lemoine, T. Crook, P. Szlosarek (2010)
Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancerInternational Journal of Cancer, 126
M. Rugge, M. Fassan, D. Graham (2015)
Epidemiology of Gastric Cancer
Raúl Aguirre-Gamboa, Hugo Gómez-Rueda, Emmanuel Martínez-Ledesma, A. Martínez-Torteya, Rafael Chacolla-Huaringa, Alberto Rodriguez-Barrientos, Jose Tamez-Peña, V. Treviño (2013)
SurvExpress: An Online Biomarker Validation Tool and Database for Cancer Gene Expression Data Using Survival AnalysisPLoS ONE, 8
Freytag (1984)
Molecular structure of the human argininosuccinate synthetase gene: occurrence of alternative mRNA splicingMol Cell Biol, 4
(2015)
ONCOLOGY REPORTS
T. Bowles, R. Kim, Joseph Galante, Colin Parsons, S. Virudachalam, H. Kung, R. Bold (2008)
Pancreatic cancer cell lines deficient in argininosuccinate synthetase are sensitive to arginine deprivation by arginine deiminaseInternational Journal of Cancer, 123
Ming-Shiang Wu, Yi‐Shing Lin, Yu-Ting Chang, C. Shun, Ming-Tsan Lin, Jaw-Town Lin (2005)
Gene expression profiling of gastric cancer by microarray combined with laser capture microdissection.World journal of gastroenterology, 11 47
S. Morris (2004)
Enzymes of arginine metabolism.The Journal of nutrition, 134 10 Suppl
C. Ensor, Frederick Holtsberg, J. Bomalaski, M. Clark (2002)
Pegylated arginine deiminase (ADI-SS PEG20,000 mw) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo.Cancer research, 62 19
N. Deng, Liang Goh, Hann Wang, K. Das, J. Tao, I. Tan, Shenli Zhang, M. Lee, J. Wu, K. Lim, Z. Lei, Glenn Goh, Qing-Yan Lim, A. Tan, Dianne Poh, Sudep Riahi, S. Bell, M. Shi, R. Linnartz, F. Zhu, K. Yeoh, H. Toh, W. Yong, H. Cheong, S. Rha, A. Boussioutas, H. Grabsch, S. Rozen, P. Tan (2012)
A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targetsGut, 61
Susann Förster, S. Gretschel, T. Jöns, M. Yashiro, W. Kemmner (2011)
THBS4, a novel stromal molecule of diffuse-type gastric adenocarcinomas, identified by transcriptome-wide expression profilingModern Pathology, 24
J. Bornschein, A. Kandulski, M. Selgrad, P. Malfertheiner (2010)
From Gastric Inflammation to Gastric CancerDigestive Diseases, 28
Roder (2002)
The epidemiology of gastric cancerGastric Cancer, 5
L. Feun, M. You, Chunjing Wu, Macus Kuo, M. Wangpaichitr, S. Spector, N. Savaraj (2008)
Arginine deprivation as a targeted therapy for cancer.Current pharmaceutical design, 14 11
W. Remmele, K.-H. Schicketanz (1993)
Immunohistochemical determination of estrogen and progesterone receptor content in human breast cancer. Computer-assisted image analysis (QIC score) vs. subjective grading (IRS).Pathology, research and practice, 189 8
S. Freytag, A. Beaudet, H. Bock, W. O'Brien (1984)
Molecular structure of the human argininosuccinate synthetase gene: occurrence of alternative mRNA splicingMolecular and Cellular Biology, 4
P. Szlosarek, M. Grimshaw, G. Wilbanks, T. Hagemann, Julia Wilson, F. Burke, G. Stamp, F. Balkwill (2007)
Aberrant regulation of argininosuccinate synthetase by TNF‐α in human epithelial ovarian cancerInternational Journal of Cancer, 121
J. Cho, J. Lim, J. Cheong, Yun‐Yong Park, Se-Lyun Yoon, S. Kim, Sang-Bae Kim, Hoguen Kim, S. Hong, Young Park, S. Noh, E. Park, I. Chu, W. Hong, J. Ajani, Ju-Seog Lee (2011)
Gene Expression Signature–Based Prognostic Risk Score in Gastric CancerClinical Cancer Research, 17
C. Ooi, T. Ivanova, J. Wu, M. Lee, I. Tan, J. Tao, L. Ward, Jun Koo, Veena Gopalakrishnan, Yansong Zhu, Lai Cheng, Julian Lee, S. Rha, H. Chung, Kumaresan Ganesan, J. So, K. Soo, D. Lim, W. Chan, W. Wong, D. Bowtell, K. Yeoh, H. Grabsch, A. Boussioutas, P. Tan (2009)
Oncogenic Pathway Combinations Predict Clinical Prognosis in Gastric CancerPLoS Genetics, 5
V. Conteduca, D. Sansonno, G. Lauletta, S. Russi, G. Ingravallo, F. Dammacco (2013)
H. pylori infection and gastric cancer: state of the art (review).International journal of oncology, 42 1
F. Izzo, P. Marra, G. Beneduce, G. Castello, P. Vallone, V. Rosa, F. Cremona, C. Ensor, Frederick Holtsberg, J. Bomalaski, Mike Clark, C. Ng, S. Curley (2004)
Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: results from phase I/II studies.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 22 10
Orditura (2014)
Treatment of gastric cancerWorld J Gastroenterol, 20
P. Szlosarek, M. Grimshaw, G. Wilbanks, T. Hagemann, Julia Wilson, F. Burke, G. Stamp, F. Balkwill (2007)
Aberrant regulation of argininosuccinate synthetase by TNF-alpha in human epithelial ovarian cancer.International journal of cancer, 121 1
S. Alberts, A. Cervantes, C. Velde (2003)
Gastric cancer: epidemiology, pathology and treatment.Annals of oncology : official journal of the European Society for Medical Oncology, 14 Suppl 2
G. Kroemer, J. Pouysségur (2008)
Tumor cell metabolism: cancer's Achilles' heel.Cancer cell, 13 6
A. Jemal, R. Siegel, Elizabeth Ward, Taylor Murray, Jiaquan Xu, M. Thun (2007)
Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 57
G. Zornoza, L. Jm, Clemente Jl, José Hernández, J. Voltas (1982)
[Treatment of gastric cancer].Revista de medicina de la Universidad de Navarra, 26 1
S. Edge, C. Compton (2010)
The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNMAnnals of Surgical Oncology, 17
Xin Chen, S. Leung, S. Yuen, K. Chu, J. Ji, Rui Li, A. Chan, S. Law, O. Troyanskaya, J. Wong, S. So, D. Botstein, P. Brown (2003)
Variation in gene expression patterns in human gastric cancers.Molecular biology of the cell, 14 8
C. Yoo, S. Noh, D. Shin, S. Choi, J. Min (2000)
Recurrence following curative resection for gastric carcinomaBritish Journal of Surgery, 87
Y. Sakamoto, S. Ohyama, J. Yamamoto, Kazuhiko Yamada, M. Seki, K. Ohta, N. Kokudo, Toshiharu Yamaguchi, T. Muto, M. Makuuchi (2003)
Surgical resection of liver metastases of gastric cancer: an analysis of a 17-year experience with 22 patients.Surgery, 133 5
J. Pinheiro, J. Boos (2004)
The best way to use asparaginase in childhood acute lymphatic leukaemia – still to be defined?British Journal of Haematology, 125
G. Gonzalez, C. Byus (1991)
Effect of dietary arginine restriction upon ornithine and polyamine metabolism during two-stage epidermal carcinogenesis in the mouse.Cancer research, 51 11
Y. Shan, Jung-Hua Fang, M. Lai, M. Yen, P. Lin, H. Hsu, Chian-Yuh Lin, Yi-Ling Chen (2011)
Establishment of an orthotopic transplantable gastric cancer animal model for studying the immunological effects of new cancer therapeutic modulesMolecular Carcinogenesis, 50
D. Rhodes, Jianjun Yu, K. Shanker, Nandan Deshpande, Radhika Varambally, D. Ghosh, T. Barrette, A. Pandey, A. Chinnaiyan (2004)
ONCOMINE: a cancer microarray database and integrated data-mining platform.Neoplasia, 6 1
L. Feun, A. Marini, G. Walker, G. Elgart, Frederick Moffat, S. Rodgers, Chunjing Wu, M. You, M. Wangpaichitr, Macus Kuo, W. Sisson, A. Jungbluth, J. Bomalaski, N. Savaraj (2012)
Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminaseBritish Journal of Cancer, 106
E. Kobayashi, M. Masuda, R. Nakayama, H. Ichikawa, Reiko Satow, M. Shitashige, K. Honda, U. Yamaguchi, Ayako Shoji, N. Tochigi, H. Morioka, Y. Toyama, S. Hirohashi, A. Kawai, T. Yamada (2010)
Reduced Argininosuccinate Synthetase Is a Predictive Biomarker for the Development of Pulmonary Metastasis in Patients with OsteosarcomaMolecular Cancer Therapeutics, 9
P. Ascierto, S. Scala, G. Castello, A. Daponte, E. Simeone, A. Ottaiano, G. Beneduce, V. Rosa, F. Izzo, M. Melucci, C. Ensor, A. Prestayko, Frederick Holtsberg, J. Bomalaski, M. Clark, N. Savaraj, L. Feun, Theodore Logan (2005)
Pegylated arginine deiminase treatment of patients with metastatic melanoma: results from phase I and II studies.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 23 30
J. Huang, S. Sridhar, Y. Chen, R. Hunt (1998)
Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer.Gastroenterology, 114 6
Aberrant expression of argininosuccinate synthetase (ASS1, also known as ASS) has been found in cancer cells and is involved in the carcinogenesis of gastric cancer. The aim of the present study was to investigate the level of ASS expression in human gastric cancer and to determine the possible correlations between ASS expression and clinicopathological findings. Immunohistochemistry was performed on paraffin‑embedded tissues to determine whether ASS was expressed in 11 of 11 specimens from patients with gastric cancer. The protein was localized primarily to the cytoplasm of cancer cells and normal epithelium. In the Oncomine cancer microarray database, expression of the ASS gene was significantly increased in gastric cancer tissues. To investigate the clinicopathological and prognostic roles of ASS expression, we performed western blot analysis of 35 matched specimens of gastric adenocarcinomas and normal tissue obtained from patients treated at the National Cheng Kung University Hospital. The ratio of relative ASS expression (expressed as the ASS/β-actin ratio) in tumor tissues to that in normal tissues was correlated with large tumor size (P=0.007) and with the tumor, node, metastasis (TNM) stage of the American Joint Committee on Cancer staging system (P=0.031). Patients whose cancer had increased the relative expression of ASS were positive for perineural invasion and had poor recurrence-free survival. In summary, ASS expression in gastric cancer was associated with a poor prognosis. Further study of mechanisms to silence the ASS gene or decrease the enzymatic activity of ASS protein has the potential to provide new treatments for patients with gastric cancer.
Oncology Reports – Spandidos Publications
Published: Jan 1, 2015
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.